A Radiomics Model for Predicting Early Recurrence in Grade II Gliomas Based on Preoperative Multiparametric Magnetic Resonance Imaging

OCIF: automatically learning the optimized clinical information fusion method for computer-aided diagnosis tasks

PURPOSE

In computer-aided diagnosis, the fusion of image features extracted from neural networks and clinical information is crucial to improve diagnostic accuracy. How to integrate low-dimensional clinical information (LDCF) with high-dimensional network features (HDNF) is an urgent problem to be solved. We offer a new network search framework to address this problem, which can provide optimized LDCF fusion and efficient dimensionality reduction in HDNF.

METHODS

OCIF innovatively uses Gaussian process optimization to explore the search space for the number of fully connected (FC) layers, the number of neurons in each FC layer, the activation function, the dropout factor, and whether to add clinical information to each FC layer. Moreover, OCIF employs transfer learning to reduce the training parameter space and improve search efficiency. To evaluate the effectiveness of the proposed OCIF, we utilized three popular end-to-end overall survival (OS) time prediction models to predict the three classes.

RESULTS

Our experimental results show that applying OCIF to a classical computer-aided diagnosis neural network can improve classification accuracy. Experiments on the 2020 BRATS dataset prove that OCIF achieves satisfactory performance, with an accuracy of 0.684, precision of 0.735, recall of 0.684, and F1-score of 0.675 on the OS time prediction task.

CONCLUSION

OCIF effectively and creatively combines clinical information and network features, leveraging both clinical information and image features to enhance the accuracy of the final diagnosis. Our experiments demonstrate that the use of OCIF can significantly improve computer-aided diagnosis accuracy, and the approach has the potential to be extended to other medical classification tasks as well.

Multimodality MRI Radiomics Based on Machine Learning for Identifying True Tumor Recurrence and Treatment-Related Effects in Patients with Postoperative Glioma

INTRODUCTION

Conventional magnetic resonance imaging (MRI) features have difficulty distinguishing glioma true tumor recurrence (TuR) from treatment-related effects (TrE). We aimed to develop a machine-learning model based on multimodality MRI radiomics to help improve the efficiency of identifying glioma TuR.

METHODS

A total of 131 patients were enrolled and randomly divided into the training set (n = 91) and the test set (n = 40). Radiomic features were extracted from the postoperative enhancement (PoE) region and edema (ED) region from four routine MRI sequences. After analyses of Spearman's rank correlation coefficient, and least absolute shrinkage and selection operator, the key radiomic features were selected to construct support vector machine (SVM) and k-nearest neighbor (KNN) models. Decision curve analysis (DCA) and receiver operating characteristic (ROC) curves were used to analyze the performance.

RESULTS

The PoE model had a significantly higher area under curve (AUC) than the ED model (p < 0.05). Among the models constructed with a single sequence, the model using PoE regional features from CE-T1WI was superior to other models, with an AUC of 0.905 for SVM and 0.899 for KNN. In multimodality models, the PoE model outperformed the ED model with an AUC of 0.931 for SVM and 0.896 for KNN. The multimodality model, which combined routine sequences and the whole regional features, showed a slightly better performance with an AUC of 0.965 for SVM and 0.955 for KNN. Decision curve analysis showed the good clinical utility of multimodal radiomics models.

CONCLUSIONS

Multimodality radiomics can identify glioma TuR and TrE, potentially aiding clinical decision-making for individualized treatment. And edematous regions may provide useful information for recognizing recurrence.

RETROSPECTIVELY REGISTERED

2021.04.15, No:2020039.

Current role of machine learning and radiogenomics in precision neuro-oncology

In the past few years, artificial intelligence (AI) has been increasingly used to create tools that can enhance workflow in medicine. In particular, neuro-oncology has benefited from the use of AI and especially machine learning (ML) and radiogenomics, which are subfields of AI. ML can be used to develop algorithms that dynamically learn from available medical data in order to automatically do specific tasks. On the other hand, radiogenomics can identify relationships between tumor genetics and imaging features, thus possibly giving new insights into the pathophysiology of tumors. Therefore, ML and radiogenomics could help treatment tailoring, which is crucial in personalized neuro-oncology. The aim of this review is to illustrate current and possible future applications of ML and radiomics in neuro-oncology.

Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm

Purpose

To investigate the value of radiomics features derived from preoperative multi-sequence MR images for predicting early recurrence (ER) in patients with solitary hepatocellular carcinoma (HCC) ≤5 cm.

Methods

One hundred and ninety HCC patients were enrolled and allocated to training and validation sets (n = 133:57). The clinical–radiological model was established by significant clinical risk characteristics and qualitative imaging features. The radiomics model was constructed using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm in the training set. The combined model was formed by integrating the clinical–radiological risk factors and selected radiomics features. The predictive performance was assessed by the area under the receiver operating characteristic curve (AUC).

Results

Arterial peritumoral hyperenhancement, non-smooth tumor margin, satellite nodules, cirrhosis, serosal invasion, and albumin showed a significant correlation with ER. The AUC of the clinical–radiological model was 0.77 (95% CI: 0.69–0.85) and 0.76 (95% CI: 0.64–0.88) in the training and validation sets, respectively. The radiomics model constructed using 12 radiomics features selected by LASSO regression had an AUC of 0.85 (95% CI: 0.79–0.91) and 0.84 (95% CI: 0.73–0.95) in the training and validation sets, respectively. The combined model further improved the prediction performance compared with the clinical–radiological model, increasing AUC to 0.90 (95% CI: 0.85–0.95) in the training set and 0.88 (95% CI: 0.80–0.97) in the validation set (p < 0.001 and p = 0.012, respectively). The calibration curve fits well with the standard curve.

Conclusions

The predictive model incorporated the clinical–radiological risk factors and radiomics features that could adequately predict the individualized ER risk in patients with solitary HCC ≤5 cm.